GlaxoSmithKline Faces Allegations in China

GlaxoSmithKline Faces Allegations in China Play

July 16 (Bloomberg) -- China is investigating at least four multinational drugmakers as it widens its probe of GlaxoSmithKline Plc, according to a lawyer in Hong Kong whose firm advises companies on cross-border anti-corruption. Olivia Sterns reports on Bloomberg Television's "Street Smart." (Source: Bloomberg)

Feed Most Popular

  • On Air Now

    In The Loop with Betty Liu Watch Now

  • Next

    Market Makers

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus